FDA Approves Pradaxa (Dabigatran Etexilate), the First Oral Anticoagulant for Children
The Food and Drug Administration approves Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets to treat venous thromboembolism (VTE) in children aged 3...